You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 6, June 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Neurology and Public Health
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (50)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cerebrovascular Disease
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Stroke

How Large a Public Health Problem, and How Can the Neurologist Help?

Graeme J. Hankey, MBBS, MD, FRCP, FRCP(Edin), FRACP

Arch Neurol. 1999;56:748-754.

Stroke is an enormous public health problem, the magnitude of which can be reduced mainly by effective stroke prevention and less so by effective treatment of acute stroke. The greatest effect is likely to be achieved by a mass approach to prevention, which consists of modification of lifestyle behaviors (eg, less smoking and less intake of salt, alcohol, and fat) among the general population through public education and, more importantly, government legislation. The appropriate identification and treatment of high-risk individuals by neurologists is likely to have a smaller but complimentary impact on the population burden of stroke and a substantial impact on the burden of stroke among individuals. The most cost-effective interventions for patients with transient ischemic attack and ischemic stroke are organized multidisciplinary acute care and rehabilitation in a stroke unit and early secondary prevention with aspirin, blood pressure control, smoking cessation, and, in the appropriate patient, oral anticoagulant therapy and carotid endarterectomy. The cost-effectiveness of carotid endarterectomy for asymptomatic carotid stenosis is highly questionable until data from ongoing trials (eg, Asymptomatic Carotid Surgery Trial) become available. Screening for asymptomatic carotid stenosis is more likely to be harmful than helpful, except perhaps among populations with a very high prevalence (pretest probability) of severe carotid stenosis. It is essential that the impact of these strategies on the incidence, outcome, and cost of stroke is measured and monitored. Currently, this is done simply, but unreliably, by examining changes in statistics that are already being measured, such as mortality (eg, among those younger than 70 years old, for greater accuracy). A growing priority in many countries is the development and implementation of valid, reliable, practical, and inexpensive methods of routinely collecting and evaluating data on stroke incidence, outcome, and cost.


From the Stroke Unit, Department of Neurology, Royal Perth Hospital, Perth, Australia.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(6):762-764.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Level and Value of Circulating Endothelial Progenitor Cells in Patients After Acute Ischemic Stroke
Yip et al.
Stroke 2008;39:69-74.
ABSTRACT | FULL TEXT  

Update on clopidogrel and dual anti-platelet therapy: neurology
Diener
Eur Heart J Suppl 2006;8:G15-G19.
ABSTRACT | FULL TEXT  

The effect of HRT on cerebral haemodynamics and cerebral vasomotor reactivity in post-menopausal women
Bain et al.
Hum Reprod 2004;19:2411-2414.
ABSTRACT | FULL TEXT  

Comparison of Hypertension Management After Stroke and Myocardial Infarction: Results From ECLAT1--A French Nationwide Study
Amar et al.
Stroke 2004;35:1579-1583.
ABSTRACT | FULL TEXT  

Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke
Mehta et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004;286:R283-R288.
ABSTRACT | FULL TEXT  

Quantitative Assessment of the Time Course of Infarct Signal Intensity on Diffusion-Weighted Images
Eastwood et al.
Am. J. Neuroradiol. 2003;24:680-687.
ABSTRACT | FULL TEXT  

Statins in Threatened Stroke
Kaste
Stroke 2003;34:351-353.
FULL TEXT  

Homonymous Visual Field Defects and Stroke in an Older Population
Gilhotra et al.
Stroke 2002;33:2417-2420.
ABSTRACT | FULL TEXT  

A national study of the quantity and cost of informal caregiving for the elderly with stroke
Hickenbottom et al.
Neurology 2002;58:1754-1759.
ABSTRACT | FULL TEXT  

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review
Gorelick
Stroke 2002;33:862-875.
ABSTRACT | FULL TEXT  

Sleep Apnea and Cardiovascular Disease
LEUNG and DOUGLAS BRADLEY
Am. J. Respir. Crit. Care Med. 2001;164:2147-2165.
FULL TEXT  

Educating the Next Generation of Physicians About Stroke: Incorporating Stroke Prevention into the Medical School Curriculum Editorial Comment: Incorporating Stroke Prevention into the Medical School Curriculum
Billings-Gagliardi et al.
Stroke 2001;32:2854-2859.
ABSTRACT | FULL TEXT  

The ABILHAND Questionnaire as a Measure of Manual Ability in Chronic Stroke Patients : Rasch-Based Validation and Relationship to Upper Limb Impairment
Penta et al.
Stroke 2001;32:1627-1634.
ABSTRACT | FULL TEXT  

Platelet glycoprotein Ib{alpha} Kozak polymorphism is associated with an increased risk of ischemic stroke
Baker et al.
Blood 2001;98:36-40.
ABSTRACT | FULL TEXT  

Stroke prevention: Narrowing the evidence-practice gap
Holloway et al.
Neurology 2000;54:1899-1906.
ABSTRACT | FULL TEXT  

Association Between High Homocyst(e)ine and Ischemic Stroke due to Large- and Small-Artery Disease but Not Other Etiologic Subtypes of Ischemic Stroke
Eikelboom et al.
Stroke 2000;31:1069-1075.
ABSTRACT | FULL TEXT  

Carotid Endarterectomy : Where Do We Draw the Line?
Gorelick
Stroke 1999;30:1745-1750.
FULL TEXT  

Carotid Atherosclerotic Plaque: Noninvasive MR Characterization and Identification of Vulnerable Lesions
Yuan et al.
Radiology 2001;221:285-299.
ABSTRACT | FULL TEXT  

CT Perfusion Scanning with Deconvolution Analysis: Pilot Study in Patients with Acute Middle Cerebral Artery Stroke
Eastwood et al.
Radiology 2002;222:227-236.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.